240 related articles for article (PubMed ID: 6414278)
1. Hemodynamic effects of antiarrhythmic drugs.
Block PJ; Winkle RA
Am J Cardiol; 1983 Sep; 52(6):14C-23C. PubMed ID: 6414278
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of class I antiarrhythmic agents.
Legrand V; Collignon P
Drugs; 1985; 29 Suppl 4():54-7. PubMed ID: 3924551
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic drugs.
Hillis WS; Whiting B
Br Med J (Clin Res Ed); 1983 Apr; 286(6374):1332-6. PubMed ID: 6132656
[No Abstract] [Full Text] [Related]
4. Antiarrhythmic drugs.
Roy D
Can Anaesth Soc J; 1986 May; 33(3 Pt 2):S65-7. PubMed ID: 2872953
[No Abstract] [Full Text] [Related]
5. Antiarrhythmic drug therapy. Recent advances and current status.
Somberg J
Cardiology; 1985; 72(5-6):329-48. PubMed ID: 2866841
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of old and new antiarrhythmic drugs.
Siddoway LA; Roden DM; Woosley RL
Cardiovasc Clin; 1985; 15(3):199-248. PubMed ID: 2870805
[TBL] [Abstract][Full Text] [Related]
7. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
Kreeger RW; Hammill SC
Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
[TBL] [Abstract][Full Text] [Related]
8. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
Pottage A
Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279
[TBL] [Abstract][Full Text] [Related]
9. [New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
Touboul P; Kirkorian G; Atallah G; Moleur P
Ann Cardiol Angeiol (Paris); 1982 Dec; 31(7):531-7. PubMed ID: 6820620
[No Abstract] [Full Text] [Related]
10. Electropharmacology of antiarrhythmic drugs.
Rosen MR; Wit AL
Am Heart J; 1983 Oct; 106(4 Pt 2):829-39. PubMed ID: 6412533
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of newer antiarrhythmic drugs.
Jewitt DE
Am Heart J; 1980 Dec; 100(6 Pt 2):984-9. PubMed ID: 6778196
[TBL] [Abstract][Full Text] [Related]
12. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Nestico PF; Morganroth J
Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
[TBL] [Abstract][Full Text] [Related]
13. New drugs in the management of ventricular arrhythmias.
Sanna GP
G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
[TBL] [Abstract][Full Text] [Related]
14. [New anti-arrhythmia drugs].
Vidal Garate J; Romero-Ayala LC; Cárdenas Loaeza M
Arch Inst Cardiol Mex; 1983; 53(2):159-78. PubMed ID: 6411015
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of encainide, flecainide, lorcainide and tocainide.
Vanhaleweyk G; Serruys PW; Hugenholtz PG
Eur Heart J; 1984 Sep; 5 Suppl B():67-74. PubMed ID: 6437819
[TBL] [Abstract][Full Text] [Related]
16. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
Camm AJ
Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
[No Abstract] [Full Text] [Related]
17. Reliability of antiarrhythmic drug plasma concentration monitoring.
Follath F; Ganzinger U; Schuetz E
Clin Pharmacokinet; 1983; 8(1):63-82. PubMed ID: 6404580
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME
Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
[TBL] [Abstract][Full Text] [Related]
19. [The interaction of antiarrhythmic drugs with other drugs].
Yamaguchi I
Kokyu To Junkan; 1985 Aug; 33(8):956-69. PubMed ID: 2866571
[No Abstract] [Full Text] [Related]
20. [Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].
Schmitz W
Klin Wochenschr; 1980 Sep; 58(18):907-18. PubMed ID: 6110804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
